Profile for Akorn Inc. (AKRX)

$ 4.61   -0.09 (-1.91%) Volume: 1.75m 4:00 PM EDT 18-Oct-2019
After Hours:  $ 4.62   0.01 (+0.22%) Volume: 6.49k 4:12 PM EDT 18-Oct-2019
Business Description:
Akorn Inc is a United States based generic pharmaceutical company. It develops, manufactures and markets generic and branded prescription pharmaceuticals as well as private-label over-the-counter consumer health products and animal health pharmaceuticals.
Address: 1925 West Field Court, Suite 300, Lake forest, IL, USA, 60045
Telephone: +1 847 279-6100 Website:
Facsimile: +1 800 943-3694 Email: [email protected]
CEO: Douglas Boothe
Employees: 2,220 Market Cap: 581.52m
Issue Type: CS
Auditor: BDO USA, LLP
Last Audit: Unqualified Opinion
Indices: Drug Manufacturers - Specialty & Generic, Morningstar US Market Factor Tilt PR USD, Morningstar US Market Factor Tilt TR USD, S&P Midcap 400, S&P Top 1000
Industry Classifications
Sector: Healthcare CIK: 3116
Industry: Drug Manufacturers
Sub-Industry:    Drug Manufacturers - Specialty & Generic
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)